FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
HealthDay News — The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug...
FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
Concurrent Treatment of Eating Disorders and PTSD Leads to Long-Term Recovery
Lag in Antidepressant Treatment Response Explained?
Pandemic-Era Telehealth Led to Fewer Therapy Disruptions
People With Long COVID Face Alarming Rates of Depression, Anxiety: Expert Q&A
Ketamine No Better for Depression Than Placebo?
Looking for a Psychiatrist that takes your Insurance?
Emotional Resilience for Mesothelioma Warriors: Mindful Living Tips
Service Dogs Help Veterans With PTSD Lead Better Lives
Running vs Meds for Depression: Is There a Clear Winner?
Confirmed: Intermittent Use of Benzodiazepines Is the Safest Option
No Link Between Most Cancers and Depression/Anxiety: Study
FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD
Alcohol Exclusion Laws Still on the Books in 18 States
15 Celebrities Open Up About Their Mental Health Battles
300 Famous Individuals with Mental Health issues, illnesses, and disorders
Cognitive Restructuring
America Has Reached Peak Therapy. Why Is Our Mental Health Getting Worse?
Use of Mental Health Services Soared During Pandemic
Suicidal Behavior Tied to Increased All-Cause Mortality in MDD